Dalrada Pharmaceutical Subsidiary, Watson Rx Solutions, Earns Prestigious NABP Specialty Pharmacy and Digital Pharmacy Accreditation
SAN DIEGO – Dalrada Financial Corporation (OTCQB: DFCO, “Dalrada”), a problem-solving innovator that takes on complex, multi-disciplinary challenges in healthcare, clean energy, climate technology, and precision manufacturing, announced today that its pharmaceutical subsidiary, Watson Rx Solutions (Watson Rx), has been accredited by the National Association of Boards of Pharmacy® (NABP®) for Specialty Pharmacy practice and Digital Pharmacy practice.
“NABP congratulates Watson Rx Solutions on achieving this important recognition”
“I’m extremely pleased with the news that Watson Rx has been recognized by the NABP and has earned these prestigious accreditations,” said Brian Bonar, Dalrada’s CEO and Founder. “We’ve made it our company-wide mission to deliver healthcare solutions and operate with responsible practices that keep people safe while furthering our long-term goals of enacting change and impacting people positively.”
The two accreditations further validate Watson Rx as a retailer that conforms and adheres to best practices and all applicable local, state, and federal laws, as well as specific rules and regulations in accordance with NABP standards.
NABP’s Specialty Pharmacy Accreditation signifies to patients, payers, and providers that the pharmacy organization is recognized for providing an advanced level of pharmacy services and disease management for patients taking medications that meet special handling, storage and distribution requirements. Specialty pharmacies coordinate patient education, promote adherence, and ensure appropriate medication use. This voluntary accreditation process required Watson Rx Solutions to demonstrate compliance with a comprehensive set of practice standards and evaluated the pharmacy on patient management, quality management, and regulatory compliance.
NABP’s Digital Pharmacy Accreditation signifies to patients, payers, and providers that the pharmacy organization is recognized for its commitment to the highest quality health care and safe pharmacy practices over the internet. The specific Digital Pharmacy Accreditation was created to recognize safe and legitimate pharmacies with an internet presence that stands out against the ever-growing list of rogue pharmacy websites. In addition to the thorough review process and on-site survey, Watson Rx Solutions’ website was verified for its online presence and medication-related website to ensure the pharmacy is properly licensed and follows applicable laws and business best practices.
Adam Myers, PharmD, and Head Pharmacist of Watson Rx Solutions commented, “With these new accreditations, we can operate with the full support and recommendation of the NABP. It’s an honor to join such an exclusive list of pharmacies committed to providing their patients with the best care and service possible.”
“NABP congratulates Watson Rx Solutions on achieving this important recognition,” said NABP Executive Director/Secretary Lemrey “Al” Carter, PharmD, MS, RPh. “By earning both Specialty Pharmacy Accreditation and Digital Pharmacy Accreditation, they demonstrate their commitment to providing patients with safe access to high-quality healthcare and improving overall health outcomes.”
About the National Association of Boards of Pharmacy
The National Association of Boards of Pharmacy® (NABP®) is the impartial professional organization that supports its member regulatory state boards of pharmacy in creating uniform regulations to protect public health. Founded in 1904, NABP aims to ensure the public’s health and safety through its pharmacist competence assessment programs, license transfer and verification services, as well as through pharmacy inspection and accreditation programs. For more information, please visit www.nabp.pharmacy.
About Watson Rx Solutions
Watson Rx Solutions has operated in the healthcare business for more than 30 years and is deeply rooted in pharmacy and the health and well-being of the community it serves.
Watson Rx Solutions aims to redefine personalized health through unique pharmacy solutions that improve patient health outcomes. It achieves this with a dedicated team of experienced professionals providing innovative care in managing complex disease states through comprehensive prescription management, education, nursing, and total health management.
Watson Rx Solutions delivers a true end-to-end pharmacy solution. For more information, please visit www.watsonrxsolutions.com.
About Dalrada Financial Corporation
Dalrada Financial Corporation (Dalrada) is a progressive organization that drives innovation to positively impact people, businesses, and the planet. The company owns and operates a global group of healthcare, climate technology, clean energy, and precision manufacturing companies. Each of these companies has a clearly-defined mandate to identify, address, and deliver solutions to unique economic, environmental, and efficiency problems facing public, government, and private sector organizations. Dalrada responds by developing advanced technologies, products, and services with a clear and quantifiable value, generating a significant return on investment for its clients.
Dalrada companies are on the leading edge of developing and applying innovative eco-sensitive next-generation science, engineering, and technology, serving a broad range of industries and governments. The company’s products and services significantly reduce energy costs and remove barriers for its clients, creating a more sustainable and prosperous future for us all.
Dalrada’s subsidiaries and strategic partners operate in the United States, United Kingdom, Malaysia, India, and Spain and are centrally managed from the company’s San Diego, CA headquarters.
For more information, please visit www.dalrada.com.
Disclaimer
Statements in this press release are not historical facts. The statements are forward-looking, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management’s current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors and will be dependent upon a variety of factors including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company’s expectations regarding these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company’s success are more fully disclosed in the Company’s most recent public filings with the US Securities and Exchange Commission (“SEC”), including its annual report on Form 10-K.
